BEGELOMAB
UNII 360N6PY2A1

Substance Identification & Data

This profile provides standardized clinical and technical data for Begelomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 360N6PY2A1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1403744-56-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

360N6PY2A1

CAS Registry Number

1403744-56-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BEGELOMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C125608

National Cancer Institute reference terminology for clinical and research data.

INN ID

9959

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Begelomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEGELOMAB

Common Names & Synonyms

BEGEDINA

BEGELOMAB [INN]

BEGELOMAB [WHO-DD]

IMMUNOGLOBULIN G2B-KAPPA, ANTI-(HOMO SAPIENS DPP4(DIPEPTIDYLPEPTIDASE 4, DIPEPTIDYLPEPTIDASE IV, ADENOSINE DEAMINASE COMPLEXING PROTEIN 2, ADCP2, TP103, T CELL ACTIVATION ANTIGEN CD26, CD26)), MUS MUSCULUS MONOCLONAL ANTIBODY

External Clinical & Regulatory Resources

Previous UNII360MTI8GF9

Next UNII360Q8Z01IP